Skip to content

Cerus CERS Operating Cash Flow

Operating Cash Flow at other companies

CorMedix logo
CorMedixCRMD
$42.38M+115%
Haemonetics logo
HaemoneticsHAE
$70.94M-39.1%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$108.1M-16.8%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$48.94M-139%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
-$33M-150%
ADMA Biologics logo
ADMA BiologicsADMA
$58.25M+396%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's operating cash flow?
Cerus (CERS) reported operating cash flow of -$3.05M in Q1 2026.
How has Cerus's operating cash flow changed year-over-year?
Cerus's operating cash flow decreased by 261.3% year-over-year, from -$844K to -$3.05M.
What is the long-term trend for Cerus's operating cash flow?
Over 4 years (2021 to 2025), Cerus's operating cash flow has grown at a -38.5% compound annual growth rate (CAGR), from -$33.92M to $4.84M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.